This article has been updated from a previous version.

NEW YORK, July 16 - Signature BioScience has acquired Cambridge Discovery Chemistry (CDC) from Millennium Pharmaceuticals, filling the company's need for chemists who can design small molecule drugs, Signature CEO Mark McDade told GenomeWeb Monday. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.